Groove Biopharma Receives $8,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2f58b2c1-ec86-4ba7-bcd8-1a4a7a0b03ab&Preview=1 - Date
12/12/2011 - Company Name
Groove Biopharma - Mailing Address
161 Eastlake Avenue E. Seattle, WA 98102 - Company Description
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. - Website
http://www.groovebiopharma.com - Transaction Type
Venture Equity - Transaction Amount
$8,000,000 - Transaction Round
Series B - Proceeds Purposes
The money is expected to run through the end of 2012, as Groove looks to select its lead drug candidates that it believes can make it through the final preclinical studies needed before the FDA will allow clinical trials to begin. - M&A Terms
- Venture Investor
Alexandria Real Estate Equities - Venture Investor
ARCH Venture Partners - Venture Investor
OVP Venture Partners - Venture Investor
Versant Ventures - Venture Investor
WRF Capital
